Janus Henderson Group
TARS icon

Janus Henderson Group’s Tarsus Pharmaceuticals TARS Stock Holding History

Janus Henderson Group’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$157M Buy
2,240,963
+310,638
+16% +$21.7M 0.08% 227
2025
Q4 		$158M Buy
1,930,325
+491,326
+34% +$36.7M 0.07% 220
2025
Q3 		$85.6M Sell
1,438,999
-367,948
-20% -$18.1M 0.04% 297
2025
Q2 		$73.2M Buy
1,806,947
+1,293,987
+252% +$58.2M 0.04% 318
2025
Q1 		$26.5M Buy
512,960
+500,478
+4,010% +$24.7M 0.01% 505
2024
Q4 		$691K Buy
12,482
+4,000
+47% +$182K ﹤0.01% 1874
2024
Q3 		$279K Hold
8,482
– – ﹤0.01% 2299
2024
Q2 		$230K Sell
8,482
-114
-1% -$3.83K ﹤0.01% 2343
2024
Q1 		$313K Buy
+8,596
New +$253K ﹤0.01% 2216

Other funds holding TARS

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Janus Henderson Group's TARS Position: Q1 2026 in Review

Janus Henderson Group increased its Tarsus Pharmaceuticals (TARS) stake by 16% in Q1 2026, buying an estimated $21.7M and bringing the position to 2,240,963 shares worth $157M. The position accounts for 0.08% of the portfolio, ranked #227.

Janus Henderson Group first reported a position in TARS in Q1 2024 and has held it in 9 quarters since. The position peaked at $158M in Q4 2025. 253 funds tracked by Wall St. Rank hold TARS as of Q1 2026.

  • Janus Henderson Group held 2,240,963 shares of Tarsus Pharmaceuticals worth $157M as of Q1 2026.
  • Janus Henderson Group bought 310,638 Tarsus Pharmaceuticals shares in Q1 2026, an estimated $21.7M.
  • Tarsus Pharmaceuticals made up 0.08% of Janus Henderson Group's portfolio in Q1 2026, its #227 holding.
  • Janus Henderson Group first reported a position in Tarsus Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • Janus Henderson Group's Tarsus Pharmaceuticals position peaked at $158M in Q4 2025.
  • 253 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.